Cargando…
Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900605/ https://www.ncbi.nlm.nih.gov/pubmed/27280602 http://dx.doi.org/10.1371/journal.pone.0157211 |
| _version_ | 1782436668409643008 |
|---|---|
| author | Fullen, Daniel J. Noulin, Nicolas Catchpole, Andrew Fathi, Hosnieh Murray, Edward J. Mann, Alex Eze, Kingsley Balaratnam, Ganesh Borley, Daryl W. Gilbert, Anthony Lambkin-Williams, Rob |
| author_facet | Fullen, Daniel J. Noulin, Nicolas Catchpole, Andrew Fathi, Hosnieh Murray, Edward J. Mann, Alex Eze, Kingsley Balaratnam, Ganesh Borley, Daryl W. Gilbert, Anthony Lambkin-Williams, Rob |
| author_sort | Fullen, Daniel J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4900605 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-49006052016-06-24 Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model Fullen, Daniel J. Noulin, Nicolas Catchpole, Andrew Fathi, Hosnieh Murray, Edward J. Mann, Alex Eze, Kingsley Balaratnam, Ganesh Borley, Daryl W. Gilbert, Anthony Lambkin-Williams, Rob PLoS One Correction Public Library of Science 2016-06-09 /pmc/articles/PMC4900605/ /pubmed/27280602 http://dx.doi.org/10.1371/journal.pone.0157211 Text en © 2016 Fullen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Fullen, Daniel J. Noulin, Nicolas Catchpole, Andrew Fathi, Hosnieh Murray, Edward J. Mann, Alex Eze, Kingsley Balaratnam, Ganesh Borley, Daryl W. Gilbert, Anthony Lambkin-Williams, Rob Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model |
| title | Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model |
| title_full | Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model |
| title_fullStr | Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model |
| title_full_unstemmed | Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model |
| title_short | Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model |
| title_sort | correction: accelerating influenza research: vaccines, antivirals, immunomodulators and monoclonal antibodies. the manufacture of a new wild-type h3n2 virus for the human viral challenge model |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900605/ https://www.ncbi.nlm.nih.gov/pubmed/27280602 http://dx.doi.org/10.1371/journal.pone.0157211 |
| work_keys_str_mv | AT fullendanielj correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT noulinnicolas correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT catchpoleandrew correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT fathihosnieh correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT murrayedwardj correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT mannalex correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT ezekingsley correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT balaratnamganesh correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT borleydarylw correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT gilbertanthony correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT lambkinwilliamsrob correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel |